Pharmafile Logo

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial costs per day of delay (appliedclinicaltrialsonline.com), so the sites chosen to participate in the trial and the support provided to them during patient recruitment can be one of the major deciding factors between an on-time trial and a delayed, over-budget trial.

- PMLiVE

🔍 Is Your Influenza Clinical Trial Ready for the Upcoming Flu Season? 🩺
The clock is ticking—flu season is just around the corner! With 86% of clinical trials failing to meet recruitment goals, it’s crucial that your sites are fully prepared to recruit patients effectively.

Our latest blog explores key strategies to enhance site motivation, streamline recruitment processes, and overcome common challenges in patient recruitment. Don’t let delays cost you—read Part #2 of our series to ensure your trial is on track for success this flu season.

🚀 Read the full blog and boost your recruitment strategy today! 👉 https://bit.ly/4cFG7ql

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Three predictions for the clinical trial industry in 2022

Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022

World Cancer Day – February 2022

World Cancer Day is celebrated around the world in February in February and innovative Trials wants to take this opportunity to raise awareness around cancer

Personalised medicine: driving a need for greater diversity in clinical trials

Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.

Cervical Cancer Prevention Month

In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer

Meet Innovative Trials at SCOPE 2022

Stop by Booth 1015 to meet the Innovative Trials' team during SCOPE 2022

Interview with Kate Shaw, Innovative Trials’ Founder/CEO

2021 has been a very busy year for Innovative Trials and Kate Shaw discusses the main highlights.

Diversity in clinical trials: looking back at our 2021 blogs

In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021

Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)

How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch

Six ways to improve diversity in clinical trials

Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...

Men’s Health Awareness Month

In this November blog, Innovative Trials will be looking at the men's health and the Movember movement which aims at raising awareness around men's health